RSS Feed For (NY:CX)

CEMEX S.A.B. DE C.V. (NY:CX)

11.09 0.09 (0.81%)
CEMEX S.A.B. DE C.V. (NY:CX) Delayed :
Previous Close $11.18    52 Week High $14.59 
Open $11.07    52 Week Low $3.94 
Day High $11.15    P/E N/A 
Day Low $10.95    EPS $0.00 
Volume 5,872,765       
More CX Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
TXT 3 RCL 3
CAL 2 CAL 2
AMX 2 AMKR 2
UA 2 LCC 2
ASR 2 ENTG 2
LCC 2 EWW 2
View All Friends, Peers and Foes

StreetInsider Reports on CX by Category

Comments on recent CX articles

ANDREW OLIVER SATCHELL
on Oct 28, 2009
at 05:29 PM
ANDREW OLIVER SATCHELL GOOD
Article: Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report
relaxed137
on Jun 14, 2009
at 05:38 PM
ASFX has a swine flu product ASFX.pk sells the thermofocus at walgreens and babies-r-us. It's a no-touch thermometer and orders are going through the roof. Buy one for yourself so you can take temperatures with out getting the swine flu! http://finance.yahoo.com/news/Safety-Product-Company-Sees-prnews-15504232.html?.v=1 This thermometer (Thermofocus) was used heavily in ASIA during SARS
Article: Swine Flu Stock Rundown
Peter
on Apr 27, 2009
at 10:51 PM
3M's New Flu Test I am surprised that this article didn't mention Response Biomedical (TSX: RBM), which makes the rapid flu test marketed by 3M as the 3M Rapid Detection Flu A + B Test. It was just launched in the fall and is a more accurate and sophisticated test than the other point of care tests on the market, like Quidel. By the way, RBM is also partnered with Roche (maker of Tamiflu) in an agreement to supply all of Roche's point of care cardiology tests and Cardiac Readers, which just launched in March of April.
Article: Swine Flu Stock Rundown

Comments on CX


No comments are currently available.